Climate Change Data Portal
DOI | 10.1016/j.taap.2016.10.005 |
Estimation of human percutaneous bioavailability for two novel brominated flame retardants, 2-ethylhexyl 2,3,4,5-tetrabromobenzoate (EH-TBB) and bis(2-ethylhexyl) tetrabromophthalate (BEH-TEBP) | |
Knudsen, Gabriel A.1; Hughes, Michael F.2; Sanders, J. Michael1; Hall, Samantha M.1; Birnbaum, Linda S.1 | |
发表日期 | 2016-11-15 |
ISSN | 0041-008X |
卷号 | 311页码:117-127 |
英文摘要 | 2-Ethylhexyl-2,3,4,5-tetrabromobenzoate (EH-TBB) and bis(2-ethylhexyl)tetrabromophthalate (BEH-TEBP) are novel brominated flame retardants used in consumer products. A parallelogram approach was used to predict human dermal absorption and flux for EH-TBB and BEH-TEBP. [C-14]-EH-TBB or [C-14]-BEH-TEBP was applied to human or rat skin at 100 nmol/cm(2) using a flow-through system. Intact rats received analogous dermal doses. Treated skin was washed and tape-stripped to remove "unabsorbed" [C-14]-radioactivity after continuous exposure (24 h). "Absorbed" was quantified using dermally retained [C-14]-radioactivity; "penetrated" was calculated based on [C-14]-radioactivity in media (in vitro) or excreta + tissues (in vivo). Human skin absorbed EH-TBB (24 +/- 1%) while 0.2 +/- 0.1% penetrated skin. Rat skin absorbed more (51 +/- 10%) and was more permeable (2 +/- 0.5%) to EH-TBB in vitro; maximal EH-TBB flux was 11 +/- 7 and 102 +/- 24 pmol-eq/cm(2)/h for human and rat skin, respectively. In vivo, 27 +/- 5% was absorbed and 13% reached systemic circulation after 24 h (maximum flux was 464 +/- 65 pmol-eq/cm(2)/h). BEH-TEBP in vitro penetrance was minimal (<0.01%) for rat or human skin. BEH-TEBP absorption was 12 +/- 11% for human skin and 41 +/- 3% for rat skin. In vivo, total absorption was 27 +/- 9%; 12% reached systemic circulation. In vitro maximal BEH-TEBP flux was 0.3 +/- 0.2 and 1 +/- 0.3 pmol-eq/cm2/h for human and rat skin; in vivo maximum flux for rat skin was 16 +/- 7 pmol-eq/cm2/h. EH-TBB was metabolized in rat and human skin to tetrabromobenzoic acid. BEH-TEBP-derived [C-14] -radioactivity in the perfusion media could not be characterized. <1% of the dose of EH-TBB and BEH-TEHP is estimated to reach the systemic circulation following human dermal exposure under the conditions tested. Chemical compounds studied in this article: 2-Ethylhexyl 2,3,4,5-tetrabromobenzoate (PubChem CID: 71316600; CAS No. 183658-27-7 FW: 549.92 g/mol logP(est): 7.73-8.75 (12)) Abdallah et al., 2015a. Other published abbreviations for 2-ethylhexyl-2,3,4,5-tetrabromobenzoate are TBB EHTeBB or EHTBB Abdallah and Harrad, 2011. bis(2-ethylhexyl) tetrabromophthalate (PubChem CID: 117291; CAS No. 26040-51-7 FW: 706.14 g/mol logP(est): 9.48-11.95 (12)). Other published abbreviations for bis(2-ethylhexyl)tetrabromophthalate are TeBrDEPH TBPH or BEHTBP. Published by Elsevier Inc. |
英文关键词 | Dermal bioavailability;Brominated flame retardant;2-Ethylhexyl 2-3,4,5-tetrabromobenzoate;Bis(2-ethylhexyl) tetrabromophthalate;Parallelogram method;Persistent organic pollutant |
语种 | 英语 |
WOS记录号 | WOS:000386992400013 |
来源期刊 | TOXICOLOGY AND APPLIED PHARMACOLOGY
![]() |
来源机构 | 美国环保署 |
文献类型 | 期刊论文 |
条目标识符 | http://gcip.llas.ac.cn/handle/2XKMVOVA/58379 |
作者单位 | 1.NCI, Lab Toxicol & Toxicokinet, 111 TW Alexander Dr, Res Triangle Pk, NC USA; 2.US EPA, Integrated Syst Toxicol Div, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA |
推荐引用方式 GB/T 7714 | Knudsen, Gabriel A.,Hughes, Michael F.,Sanders, J. Michael,et al. Estimation of human percutaneous bioavailability for two novel brominated flame retardants, 2-ethylhexyl 2,3,4,5-tetrabromobenzoate (EH-TBB) and bis(2-ethylhexyl) tetrabromophthalate (BEH-TEBP)[J]. 美国环保署,2016,311:117-127. |
APA | Knudsen, Gabriel A.,Hughes, Michael F.,Sanders, J. Michael,Hall, Samantha M.,&Birnbaum, Linda S..(2016).Estimation of human percutaneous bioavailability for two novel brominated flame retardants, 2-ethylhexyl 2,3,4,5-tetrabromobenzoate (EH-TBB) and bis(2-ethylhexyl) tetrabromophthalate (BEH-TEBP).TOXICOLOGY AND APPLIED PHARMACOLOGY,311,117-127. |
MLA | Knudsen, Gabriel A.,et al."Estimation of human percutaneous bioavailability for two novel brominated flame retardants, 2-ethylhexyl 2,3,4,5-tetrabromobenzoate (EH-TBB) and bis(2-ethylhexyl) tetrabromophthalate (BEH-TEBP)".TOXICOLOGY AND APPLIED PHARMACOLOGY 311(2016):117-127. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。